From: Physical Activity on Telomere Length as a Biomarker for Aging: A Systematic Review
References | Subjects | Cell type | Measurement method | Exercise intervention | Main results |
---|---|---|---|---|---|
Laye et al. [107] | 8 men and 1 woman, endurance athletes (44 ± 2 years, 7 male) | TL, Telomerase (hTERT, hTERC) and shelterin complex proteins (e.g. TRF2): PBMC and skeletal muscle | qPCR | Endurance athletes: completed ≥ 1 ultra-marathon of ≥ 60 km PA: daily marathon distances, total 183 miles over 7 days TL & telomerase: blood samples and muscle biopsy pre- (2 wks before) and post- (22-24 h after) competition | No significant difference in rTL or telomerase activity with ultra-endurance PA (telomerase activity not detectable in skeletal muscle) Significant increase in mRNA expression of shelterin complex proteins in PBMCs Higher TRF2 found in skeletal muscle versus PBMCs |
Borghini et al. [47] | 62 men and women n = 20 endurance athletes (45.4 ± 9.2 years) n = 42 sedentary controls (45.9 ± 9.5 years) | TL: Saliva | qPCR | Endurance athletes: history of 59.4 km/week ultra-trail running for 13.15 years, ages grouped into tertiles PA: 330 km trail with incline of 24,000 m, duration of < 150 h TL: samples at baseline (1–2 d before race), intermediate point (148 km), and race completion (< 1 h) Controls: healthy, inactive, no competitive sports history | ↓ Significantly reduced rTL in group of endurance athletes with PA (at intermediate point and at race completion) versus baseline ↑ Significantly longer TL in endurance athlete group (pre-PA) versus controls, largest difference of TL in older (≥ 53 years) group (pre-PA) versus age-matched controls |
Diman et al. [131] | 10 men, healthy, moderately active (20 ± 0.6 years) n = 5 low-intensity group n = 5 high-intensity group | TERRA: Skeletal muscle | qRT-PCR | PA: 45 min cycling, with target of 50% VO2 peak (low-intensity) and 75% VO2 peak (high-intensity) of endurance exercise TERRA: biopsies before, immediately after, and 2.5 h after PA | ↑ Significant increase of TERRA levels immediately after and 2.5 h after PA versus before PA, for in both high- and low-intensity groups |
Cluckey et al. [127] | 19 men and women, healthy n = 11 young group (22 ± 2 years) n = 8 older group (60 ± 2 years) | Telomerase (hTERT and TRF2): PBMC | qRT-PCR | PA: 30 min cycling, varied workloads, with target of 90% VO2 max (high-intensity) TL: blood samples pre-PA, and at 30, 60, and 90 min post-PA | ↑ Significant increase in relative hTERT levels with high-intensity PA versus pre-PA (greater increase in young group) Highest post-PA hTERT levels at 60 min for the older group and at 90-min for younger group ↑ Significantly greater increase in hTERT and TRF2 expression in men versus women, independent of age |
Gagnon et al. [98] | 25 men and women n = 15 expedition group (23.5 ± 7.4 years) n = 10 controls (31.1 ± 10.8 years) | TL: Leukocytes | qPCR | PA: 260 km canoeing expedition (6–9 h/d) low to moderate intensity, for 14 days TL: blood pre- (24 h before) and post- (3 h after) expedition | No significant change in TL between the expedition and control groups |
Denham et al. [167] | 34 men, healthy (31 ± 10 years) | TL: sperm | qPCR | Cardiopulmonary exercise test to exhaustion Intervention: 3 sessions/week of sprint intervals for 6 wks, vigorous intensity; conducted by a subset (n = 10) TL: sperm donation before the test (n = 34); post PA intervention (n = 10) | No significant correlations between TL, fitness or exercise performance Positive correlation between TL and improvements in cardiorespiratory fitness after intervention |
Brandao et al. [56] | 20 women, premenopausal, obese (20–40 years) | TL: Leukocytes | qPCR | PA: 165 min/week (55 min/session, with 3 sessions/week) for 8 wks PA intensity: 75–90% HRmax and increasing multiple RM TL: blood samples pre- and post-PA intervention | ↑ Significant increase in rTL with post-PA versus pre-PA ↑ Significant inverse correlation between TL and waist circumference post-PA versus pre-PA |
Hernando et al. [123] | 149 men and women, healthy, non-smoking (19–67 years) n = 96 ultra-trail runners n = 53 sedentary controls | TL: Blood; SOD2 rs4880: Saliva | qPCR | Endurance athletes: history of ≥ 1 ultra-marathon of ≥ 60 km PA: 107 km ultra-trail race TL: blood samples pre- (1 d before) and post- (1–2 d) competition | ↑ Significantly longer TL in older/elderly runners (≥ 40 years) versus age-matched controls Significant association of shorter rTL with SOD2 rs4880 polymorphism No difference in rTL with previous race training |